LTEKAST- Tablets

Each film-coated tablet contains: Montelukast sodium equivalent to montelukast 10 mg.

Levocetirizinedihydrochloride 5 mg Excipients q.s.

DESCRIPTION - Montelukast sodium is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene (CysLT1), receptor. Levocetirizine is the R-enantiomer of cetirizine. Levocetirizine is an orally active, potent, selective and long acting H1 -histamine receptor antagonist with no anticholinergic activity. Recent studies have demonstrated that Allergic Rhinitis [AR] when treated concomitantly with an antileukotriene (montelukast) and an antihistamine (levocetrizine), shows significantly better symptom relief compared with the modest improvement of rhinitis symptoms with each of the treatments alone.

INDICATIONS - LTEKAST Tablets are indicated for relief of symptoms of allergic rhinitis [seasonal or perennial], as prophylaxis in seasonal allergic rhinitis and treatment of comorbid asthma and allergic rhinitis in patients 15 years of age and over.

DOSAGE & ADMINISTRATION Adults [>15years]: 1 LTEKAST Tablet once daily.

PRESENTATION LTEKAST Tablets is available in a strip of 10 tablets.

STORAGE Store in a cool dry place. Protect from moisture and light.

Read 1118 times